Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern

Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern

Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern,
Mumps und Röteln
Vaccination against measles, mumps and rubella (commonly known as "German
measles")
Measles, mumps and rubella are widely spread diseases which are caused by infection with
viruses (measles virus, mumps virus, rubella virus) and appear not only in children but also in
adults. As the vaccinations against measles, mumps and rubella are in most cases done in
combination, i.e. by injecting the three vaccines in one syringe (so-called MMR vaccination),
the diseases and vaccination questions will be dealt with here in common.
Drugs to heal measles, mumps or rubella are not available. The best way to protect oneself
from these diseases is to undergo an MMR vaccination in time!
Measles frequently takes a serious course and is easily transmitted from person to person. It is
accompanied by high fever, cough, conjunctivitis and a typical rash (exanthema) and lasts
about two weeks. Frequent complications are lung infections as well as inflammations of the
middle ear. In about one in 1,000 to 2,000 measles patients, an encephalitis arises which can
lead to permanent intellectual impairment and physical disability. Especially for adults
measles is a risk as these complications occur in them in large numbers.
Mumps is a virus infection which is accompanied by fever, headache and swelling of the
salivary glands. In at least every tenth mumps patient, it is accompanied by an inflammation
of the cerebral membrane (meningitis) and occasiona lly an inflammation of the brain
(encephalitis). A rare but typical complication of mumps is deafness. In every fourth juvenile
or adult male swelling and inflammation of the testes occurs, which in rare cases can lead to
sterility.
Rubella (or German measles) is a mild virus disease accompanied by fever, rash (exanthema)
and swollen glands. If rubella arises during pregnancy, the infection can pass to the unborn
child and cause defective development of the eyes, ears, heart and brain. Though the infection
with the rubella virus sometimes is not accompanied by symptoms, these persons can
nevertheless infect the persons they come into contact with.
Seite 2 der Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern, Mumps und
Röteln
Vaccine
The measles/mumps/rubella vaccine consists of attenuated living viruses of the three kinds
which multiply in the vaccinated person; the vaccine is injected (administered by
intramuscular or subcutaneous injection) .
Who should be vaccinated and when?
The combined measles/mumps/rubella vaccine is recommended for all children (boys and
girls) between their completed 11th and 14th month. Should the vaccination not be performed,
it can be done at any later date. If a child has been enrolled for a day care establishment or the
like, the first MMR vaccination can also be done before the 12th but not before the 9th month.
If the first vaccination has been administered before the 12th month, the second vaccination
must be done before the age of two.
To ensure safe immunization, an MMR booster is done for all children between their
15th and 23rd month. The MMR booster can be performed as early as four weeks after the first
vaccination.
Hint: The Permanent Vaccination Commission does not recommend an additional rubella
vaccination for girls if two vaccinations with MMR vaccine have already been carried out. If
only one MMR vaccination has been made, the second MMR vaccination is still to be
performed; within the scope of the Juvenile Health Examination it should be checked whether
all young persons have received two MMR vaccinations. The double vaccination against
measles, mumps and rubella for all children, i.e. girls and boys, prevents the viruses from
further circulating in the population so that, for example, a boy could not infect a pregnant
woman with rubella. The measles/mumps/rubella vaccination of persons who are already
immune against one or two of these diseases is without risk.
Who should not be vaccinated?
Persons suffering from an acute illness with fever requiring treatment should not be
vaccinated. Neither should children with an immune deficiency syndrome – congenital,
acquired or due to medication – be vaccinated; in such cases you should ask your doctor in
which way protection at least against individua l diseases can be achieved.
The MMR vaccination should not be administered to persons having received
immunoglobulin (gamma globulin) in the last three months or who during the same period
have undergone a blood transfusion. (The antibodies against the viruses mentioned which are
transmitted in this process can lead to the vaccination being without effect.) If an MMR
vaccination is planned for adults, it should
Seite 3 der Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern, Mumps und
Röteln
not be administered to pregnant women since there possibly is a risk – a theoretical one which
has not been proved in practice - for the unborn child from the vaccination virus. For the same
reason, pregnancy should be avoided during at least three months after the vaccination.
Behaviour after the vaccination
The vaccination viruses are not transmitted to contact persons so that the vaccination of a
child is without risk even if a pregnant woman lives in the surroundings.
Potential reactions after the vaccination
During or shortly after the measles/mumps/rubella vaccination, mild burning, swelling or
redness can occur at the site of vaccination. About six to 14 days after the vaccination, a
temperature rise of short duration (one to two days) can occur, accompanied by fatigue and
rash; also, the eyes or the trachea can be irritated. Occasional swelling of the salivary glands
or the lymph nodes has been observed; not quite so young persons and adults are observed to
suffer from transitory articular pain. In individual cases, the testes or the pancreas can be
affected. The vaccination reactions are mild and usually do not require medical treatment.
Complications
In connection with a febrile reaction, febrile convulsions can in some cases result. In very rare
cases oversensitiveness to the vaccine in the form of nettle-rash fever and other allergic
symptoms can occur; the cerebral membranes can be irritated, and a mild encephalitis is
theoretically possible. Coagulation disorders are extremely rare.
Nothing is known about whether permanent damage to health can occur after this vaccination.
If you nevertheless observe unusual symptoms in the vaccinated person, you can ask the
vaccination doctor for advice.
Seite 4 der Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern, Mumps und
Röteln
Mr./Mrs.
Vaccination
against measles,
mumps and rubella
at
Enclosed you find a leaflet on the performance of the vaccination against measles, mumps
and rubella, which contains the most important information about the diseases which can be
prevented by vaccination, about the vaccine, the vaccination, reactions and potential
complications as well as information about how to behave after the vaccination.
You are requested to provide the following information before the vaccination:
(1)
Does the person to be vaccinated suffer from an immune deficiency syndrome
(acquired, congenital, due to medication)?
¡ yes
(2)
Did the person to be vaccinated receive immunoglobulin (gamma globulin) in the past
three months or was a blood transfusion made?
¡ yes
(3)
¡ no
¡ no
Did the person to be vaccinated undergo a vaccination in the past four months or is a
vaccination against other diseases planned in the next four weeks?
¡ yes
¡ no
if yes, which one: …………………………………………………….
(4)
In the case of women of child bearing age: Is the woman pregnant at present?
¡ yes
¡ no
Should you wish for additional information about the vaccination against measles, mumps and
rubella, ask your vaccinating doctor!
Please bring along the vaccination card!
Seite 5 der Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern, Mumps und
Röteln
Declaration of consent
to the performance of the vaccination against
measles, mumps and rubella
Name of person to be vaccinated................................................................................
born on.....................................................................................................................
I have taken note of the contents of the leaflet on the vaccination against measles, mumps and
rubella, and I have been told that I can get additional information from the vaccinating doctor.
¡ I do not have any further questions.
¡ I agree to the suggested vaccination against measles, mumps and rubella.
¡ I decline the vaccination. I have been informed about potential disadvantages as a
result of the refusal of this vaccination.
Notes: ...................................................................................................................
...............................................................................................................................
Place, date: ...........................................................................................................
...........................................
Signature of person to be
vaccinated or person having
custody
.......................................................
Doctor's signature
Seite 6 der Aufklärung in englischer Sprache zur Schutzimpfung gegen Masern, Mumps und
Röteln
You can contact the vaccinating doctor as follows:
___________________________________________________________
___________________________________________________________
___________________________________________________________
Translation of the original of the information leaflet by courtesy
of Deutsches Grünes Kreuz e.V. on behalf of the Public Health
Department of the Helmstedt District in November 2002
Übersetzung des Originals des Aufklärungsblattes mit freundlicher
Genehmigung des Deutschen Grünen Kreuzes e.V. im Auftrag des
Gesundheitsamtes des Landkreises Halberstadt - im Jahr 11/2002.